PDL BioPharma Inc (NASDAQ:PDLI)

7.18
Delayed Data
As of Apr 17
 0.00 / 0.00%
Today’s Change
6.52
Today|||52-Week Range
10.26
-6.87%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Operating ActivitiesNet Income / Starting Line72.9M92.1M102.2M55.1M
 
 
 
 
 
Depreciation11.9M------
 
 
Total Other Cash Flow11.1M-40.3M-23.3M33.7M
 
 
 
 
 
Funds From Operations94.9M38.3M75.0M75.5M
 
 
 
 
 
Funds From/For Other Operating Expenses3.1M-16.1M-2.1M6.4M
 
 
 
 
 
Net Cash Flow - Operating Activities91.8M54.4M77.1M69.0M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.000.00-1.8M
 
 
Decrease In Investments0.000.000.003.5M
 
 
Capital Expenditures0.00-39.0K-10.0K0.00
 
 
 
Other Investing - Uses0.00-215.0M0.00-15.0M
 
 
 
Other Investing - Sources0.0049.5M32.3M89.5M
 
 
 
 
Net Cash Flow Investing-50.0M-131.1M32.3M10.7M
 
 
 
 
 
 
FinancingShort Term Borrowings-18.8M-18.8M-18.8M-18.8M
 
 
 
 
 
Long Term Borrowings290.2M0.00537.0K-538.0K
 
 
 
 
Long Term Debt Reduction-29.9M0.000.00-26.3M
 
 
 
Net Proceeds Stock Sale11.4M0.000.000.00
 
 
Common Preferred Redeemed0.000.000.00-31.0M
 
 
Common Dividends----------
Cash Dividends Paid - Total-24.0M-24.0M-24.0M-24.4M
 
 
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing31.0M0.000.00-31.0M
 
 
 
Net Cash Flow - Financing198.0M-42.8M-42.3M-70.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.000.000.00--
 
Net Change In Cash239.7M-119.5M67.1M9.8M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account